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Background: Post-treatment follow-up visits for gynecological cancer survivors should provide opportunities for
management of adverse physical/psychological effects of therapy and early recurrence detection. However, the
adequacy of such visits in Japan is poorly documented. We qualitatively explored care-seeking experiences of
Japanese gynecological cancer survivors and deduced factors influencing care-seeking behaviors and treatment
access.
Methods: We conducted 4 semi-structured focus groups comprising altogether 28 Japanese gynecological cancer
survivors to collect a variety of participants’ post-treatment care-seeking behaviors through active interaction with
participants. Factors influencing access to treatment for adverse effects were analyzed qualitatively.
Results: Survivors sought care through specialty clinic visits when regular post-treatment gynecological follow-ups
were inadequate or when symptoms seemed to be non-treatment related. Information provided by hospital staff
during initial treatment influenced patients’ understanding and response to adverse effects. Lack of knowledge and
inaccurate symptom interpretation delayed help-seeking, exacerbating symptoms. Gynecologists’ attitudes during
follow-ups frequently led survivors to cope with symptoms on their own. Information from mass media, Internet,
and support groups helped patients understand symptoms and facilitated care seeking.
Conclusions: Post-treatment adverse effects are often untreated during follow-up visits. Awareness of possible
post-treatment adverse effects is important for gynecological cancer survivors in order to obtain appropriate care if
the need arises. Consultation during the follow-up visit is essential for continuity in care.
Keywords: Health behavior, Adverse effects, Gynecological cancer, Quality of health care, Post-treatment follow-upBackground
Many survivors of gynecological cancer suffer from
persistent adverse post-treatment effects [1]. Reported
post-treatment symptoms include constipation/diar-
rhea, lymphedema, menopausal symptoms, sexual and
vaginal dysfunction, and neurotoxicity [2-5]. Physical
sequelae lead to higher levels of depressive symptoms
[6]. In the case of patients undergoing long-term treat-
ment, these symptoms tend to result in lowered quality-
of-life and unmet needs for symptom management
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reproduction in any medium, provided the orEffective management of late complications of cancer
treatment would contribute to the well-being of cancer
survivors [9]. Hence, it is imperative to understand the
experiences of gynecological cancer survivors during care
for adverse treatment outcomes; unfortunately, this aspect
has not been well studied [1]. Routine post-treatment
follow-up visits provide gynecological cancer survivors
opportunities for management of physical/psychological
adverse effects and early recurrence detection [10-12].
However, in Japan, there is sparse documentation of the
follow-up experiences of gynecological cancer survivors
suffering from prolonged symptoms.
Japan has a universal health insurance system that
allows patients to choose any specialty clinic of their
choice. All patients are covered under the insurance re-
gardless of their disease. In this system, registration of
patients with general physicians and gatekeeping byl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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continuity and comprehensiveness of primary care re-
main poor [13]. Therefore, post-treatment follow-up is
provided usually by cancer specialists. Patients consult
cancer specialists directly after the treatment at regular
but decreasing intervals over several years. Proposed
gynecological cancer follow-up programs in the clinical
guidelines are similar to those of Western countries, but
these programs are often more frequent and intensive
than those of Western countries [14].
Gynecological cancer survivors are usually considered
to consult cancer specialists for post-treatment symp-
toms. However, as mentioned above, Japan’s health
insurance system allows cancer survivors to be examined
and treated for post-treatment symptoms at any specia-
list clinic of their choice. Therefore, the purpose of this
study was to explore qualitatively the care-seeking
experiences, both during and outside of follow-ups, of
post-treatment Japanese gynecological cancer survivors
suffering from adverse effects. We also examined factors
influencing care-seeking behaviors and access to treat-
ment for adverse symptoms.
Methods
Participants and data collection
A qualitative approach was chosen for this research for
the following reasons: first, qualitative research has advan-
tages for exploring subjective experiences and understand-
ing of the study participants [15], and second, qualitative
methods have been used to study care seeking behaviors
in published literature [16,17]. Focus groups, a type of
group interview, were adopted to promote self-disclosure
and active discussion through interaction of a small num-
ber of participants [18].
The data used in the study were part of a larger quali-
tative project that explored the perspectives of post-
treatment care of gynecological cancer survivors. We
sought gynecological cancer patients on follow-up 1–10
years post-treatment without recurrence by invitation in
a newsletter sent to approximately 400 members of a
Japanese gynecological cancer support group based in
Hokkaido. This recruitment strategy was chosen to
collect a wide range of experiences from survivors
attending different hospitals. Of the 32 women who
showed interest, one cervical cancer survivor who post-
treatment period was less than 1 year and two breast
cancer survivors were excluded. Before the focus group
interviews, a questionnaire was mailed to obtain each
participant’s profile (Table 1).
Four focus groups comprising 6–8 participants each
were formed. Semi-structured group interviews were
conducted in each group to discuss post-treatment
experiences related to follow-up and expectations
regarding treatment by health professionals. After theintroduction, participants were asked to express their
views regarding their experiences and perspectives in
post-treatment care and symptoms using the following
open-ended questions: (1) what do you think about
post-treatment care?; (2) if you had a problem after
treatment, was it solved in post-treatment care?; and
(3) are you satisfied with post-treatment care and why?.
The answers were explored further if participants
touched on their experiences of care seeking. The ses-
sions were conducted during November and December
2009 at local community centers in four different
regions of Hokkaido. As the participants touched on
their experiences while seeking care for adverse effects,
the interviewer probed deeper into the answers.
The research protocol for this study was approved by
the ethics committee of Hokkaido University Graduate
School of Medicine. All participants received detailed in-
formation about the study and provided written consent.
The principal author (SO) conducted all interviews. Each
session lasted 60–90 min and was audio taped with
permission and transcribed verbatim. One participant
requested that her data be withheld; thus, focus-group
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lysis. The participants were aged 41–71 years. Participants’
cancers included major gynecological malignancies, which
helped us to explore the diversity in the care-seeking
experiences of gynecological cancer survivors. Nine survi-
vors had cervical cancer, 11 had endometrial cancer, 7 had
ovarian cancer, and 1 had vulvar cancer. Post-treatment
period was ≤5 years for 17 survivors and 5–10 years for 11
survivors. Twelve survivors had been treated with surgery
alone; 15 had received surgery and chemotherapy; and 1
had received surgery, chemotherapy, and radiation therapy.
Regarding educational background, 2 survivors had not
graduated from high school, 17 were high school graduates,
and 9 were college graduates.
Data analysis
Using thematic analysis, accounts of participants’ care-
seeking behaviors were coded and grouped into categories
according to commonalities and differences [19]. Relation-
ships among categories were determined by extracting
statements defining category–category connections. Data
analysis was continued until data saturation, in which no
new categories and category–category connections were
extracted. The category–category connections were visua-
lized by diagramming care-seeking pathways to treatment
and factors influencing the process of receiving treatment,
by using an event flow network technique recommended
by Miles and Huberman [20].
The supervisor (MM) and other team members (KK,
TT, and HK) discussed data validity and altered codes and
categories when necessary.non-treatment 
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Participant data revealed care-seeking experiences for
16 types of post-treatment symptoms: lymphedema
(16 women), urinary disorder (9), menopausal symp-
toms (2), fatigue (2), numbness (2), taste disorder
(1), pain (1), irritability (1), depression (1), bowel ob-
struction (1), abdominal pain (1), constipation (1),
cystitis (1), palpitation (1), inguinal hernia (1), and
disk hernia (2). The description of inguinal hernia
and disk hernia refers to symptoms that worsened
after treatment.
Analysis revealed 10 categories related to careseeking:
“knowledge and interpretation,” “persistent or worsened
symptoms,” “groping for answers,” “gynecological consult-
ation at follow-up,” “non-treatment,” “symptom alleviation
or disappearance,” “referral,” “obtaining information through
people and media,” “visit to specialist clinic of choice,” and
“treatment or advice.” The study identified 15 types of cat-
egory–category relationships, as shown in Figure 1.
The category–category relationships revealed that
patients receive treatments for adverse effects
through 2 pathways: “gynecological consultation at
follow-up” and “visit to specialist clinic of choice.”
Three factors, namely, “knowledge and interpret-
ation,” “non-treatment,” and “obtaining information
through people and media,” were found to directly
influence care reception at the 2 pathways leading to
treatment. Descriptions of these 2 pathways and 3
factors are given below. The other 5 categories are
also indicated in relation to these 2 pathways and the
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Among the two observed pathways, gynecological con-
sultation at follow-up visits presented as an important
opportunity for symptomatic women to seek care. Ten
women described their experience of consulting gynecol-
ogists about their post-treatment symptoms at follow-up
visits. They told their gynecologists about feelings of dis-
comfort, pain, or symptoms similar to those described to
them prior to discharge after initial treatment.
“I felt grumpiness when preparing meals or doing
something similarly insignificant so that I even felt like
beating on a rice bowl or something. . .when he asked
me how I was doing, I told him about it and that I felt
burning and couldn’t sleep. He prescribed me a pill.”
(#15, 1 year after treatment)
At follow-up consultations, women experienced 3
types of responses from gynecologists in reaction to
their symptoms: (1) “treatment or advice,” (2) “referral,”
or (3) “non-treatment.” Treatments received at follow-
up included drug prescriptions for menopausal symp-
toms, urinary disorders, and swollen legs (“treatment or
advice”). Physicians referred lymphedema patients to
outpatient clinics specializing in particular symptoms.
Urinary disorders, menopausal symptoms, and disk/in-
guinal hernia patients received recommendations to visit
other departments or local clinics (“referral”). “It was
about half a year after the treatment when I told my
doctor that I felt something was wrong. He said “I
expected that” and recommended that I buy a special
stocking. . .but the symptom didn’t get better. In the next
visit, the doctor recommended that I visit a lymphedema
clinic.” (#11, 6 year after treatment)
One woman told that she had consulted her doctor
but was unsure about the timing of treatment. “When I
told my doctor at follow-up about inguinal hernia, he
said that he could refer me to a specialist. However,
sometimes the discomfort continues and sometimes it
disappears. So I waited while wondering whether some-
day I will have to receive surgery.” (#10, 5 years after
treatment)
Visit to specialist clinic of choice
In addition to follow-ups, women sought care at nearby
clinics and from departments other than gynecology at
the hospitals where they received cancer treatment. A
total of 10 experiences were described by 6 women.
They visited 5 types of clinical doctors; internists, psy-
chiatrists, urologists, lymphedema specialists, and acu-
puncture therapists. Women cited 3 reasons for visiting
doctors outside of follow-up: (1) they did not think that
their symptoms were related to cancer treatment,
(2) they did not receive treatment at follow-ups, and
(3) they thought that there was no point in consulting
the gynecologist at follow-up.One woman said she visited a nearby urologist when
she experienced urine leakage after treatment. There,
she received information for the first time that her
symptom was a result of cancer treatment. “I felt some-
thing was wrong and visited a urologist. . . I understood
what was happening when he told me it was because of
the surgery. . .he was the first person to tell me that
gynecological surgery could disrupt the bladder.” (#26, 4
years after treatment) She added that she was not
informed that the surgery for cancer treatment could
cause urinary disorder.
Another woman who received no treatment or in-
struction when consulting a gynecologist about swollen
legs at a follow-up said she visited a lymphedema clinic
that she herself had found. “There was no treatment or
instruction on how to ease symptoms at that time. So I
looked for a lymphedema clinic, visited there on my own
judgment, and learned about self-care. . .I could manage
to solve my problems by making my own decision of
consulting a specialist.” (#27, 6 years after treatment)
Those who believed that there was no point in con-
sulting the gynecologist at follow-up said that they felt
this way because their doctors had changed or because
of the hospital’s attitude when they were in-patients. “If
you were to see the same doctor who treated you, you
might be able to complain or tell him that you ended up
having such-and-such symptoms. But, all of the doctors
who were in charge of my treatment have left, and I am
afraid that there is no point complaining to my current
doctor. So I think I have no choice but to see a urologist
about urinary problems.” (#14, 7 years after treatment)
Description about 3 factors influencing care reception,
“knowledge and interpretation,” “non-treatment,” and
“obtaining information through people and media” is
given below:
Knowledge and interpretation
Among factors influencing the treatment process, scar-
city of information and incorrect interpretation of the
symptoms were the leading factors influencing the lack
of need for the women to seek professional care for their
adverse effects. Knowledge about adverse effects and
interpretations of signs and symptoms affected whether
women sought care and how they participated in care.
Eleven women said they received information about pos-
sible adverse effects by hospital staff before surgery or at
discharge. They obtained knowledge through surgical
consent forms, pre-operative consultations, and dis-
charge documents. Possible adverse effects mentioned
on those occasions included lymphedema, urinary dys-
function, neurotoxicity, and menopausal symptoms.
Those who developed urinary dysfunction before dis-
charge also gained knowledge through their treatment
experience at that time. The majority of informed
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periencing signs or symptoms. “I was told by the doctor
that I would develop lymphedema and visited the clinic
referred by the doctor.” (#09, 1 year after treatment)
In contrast, 5 women claimed that they had not received
information on adverse effects from hospital staff before
discharge. Some of these women visited nearby clinics
when symptoms developed, while the others did not even
think about seeking care, ignoring their symptoms until
they worsened and only later realizing that their symp-
toms, including depression, lymphedema, and urinary
dysfunction, were effects of gynecological cancer and
treatment. One woman said she knew nothing about lym-
phedema even after she first developed the symptom soon
after surgery. Unable to realize that her symptom was
treatment related, she spent her daily life with prolonged
symptoms. Her symptoms were persistent and suddenly
worsened (“persistent or worsened symptoms”). “I felt
tingling pain in my right leg soon after the surgery. I
thought it was an effect of anesthesia and would be better
soon, but the pain continued. After discharge, I made
myself walk around the neighborhood to build up my
strength. Soon I found my leg got very swollen. I was so
surprised.” (#29, 3 years after treatment) It was at this
point that she visited her gynecologist.
Interpretation of symptoms affected whether women
sought care or not. Three women who did not seek care
accepted the symptoms as signs of old age or a legacy of
treatment. Others thought they could manage the symp-
tom or that the symptoms would disappear soon. Some
women whose chronic symptoms worsened after treat-
ment did not seek care because the symptom had existed
before cancer treatment.
One woman who experienced fatigue but did not seek
care voiced her concern about the interpretation of her
symptoms. “I wonder where this fatigue comes from. Is
it just because I am physically weak or due to the sur-
gery that removed cancer? Does this have anything to
do with the removal of lymph nodes? I felt so exhausted
after working 4 hours a day and cannot continue work-
ing anymore.” (#30, 2 years after treatment)
Many women who realized the connection between
symptoms and cancer treatment wished that they had
received information earlier. One woman who visited a
psychiatrist after a year of worry about depressing
feelings said, “After wondering for some time why I felt
pains in my chest and back, I thought it might be stress
and visited a psychiatrist. He said it could be some kind
of psychiatric effect since there were no such symptoms
before. . .the symptom gradually disappeared. . .If I knew
such symptoms would occur after treatment before-
hand, I would’ve understood the symptom.” (#26, 4
years after treatment) Here, she also illustrated her days
of wondering what to do with prolonged symptoms(“groping for answers” and “persistent or worsened
symptoms”).
Non-treatment
Women with pain, lymphedema, and neurotoxicity said
that their doctors did not provide care for adverse effects
at follow-up when they first complained about the symp-
toms. Among 12 women who claimed of not receiving
care at follow-ups, 5 received a diagnosis but did not re-
ceive treatment, while 7 received neither a diagnosis nor
the treatment. Women’s recollections of their doctors’
explanations for non-treatment included statements
such as “the symptom was not serious,” there was “no
treatment for the symptom,” or “it would disappear over
time.” Some doctors simply said that they had no know-
ledge of the symptom.
Among those women who were told by gynecologists
that their symptom would disappear, one woman experi-
enced remission of the symptom (“symptom alleviation
or disappearance”). One woman who had a taste dis-
order after chemotherapy said, “The doctor told me it
would disappear over time. I said ‘I see.’ I know there
are people whose symptoms did not disappear after sev-
eral months, but in my case, my taste recovered in a
month and a half or so. So, I thought it did recover once
the treatment completed.” (#12, 1 year after treatment)
However, there were women whose symptoms contin-
ued or worsened (“persistent or worsened symptoms”).
For example, one woman who suffered numbness in her
toes after chemotherapy said she was distressed by the
duration of the symptom. She repeatedly complained
about the symptom at follow-ups, but her doctor kept
telling her to wait. The doctor’s attitude perturbed her.
“He said it would disappear soon. However, as time
elapsed, he initially said it would take 3 years and then
later said 4 years. I wondered whether he didn’t care
enough to treat me or didn’t know how to.” (#02, 1 year
after treatment)
Obtaining information through people and media
Symptomatic women who did not interpret the symp-
tom as a result of cancer treatment or who did not re-
ceive the treatment while consulting their gynecologists
at follow-ups described how they groped for answers to
find ways to ease their symptoms (“groping for answers”).
For those women, information played a key role in
obtaining treatment. Those who obtained useful infor-
mation were able to take a step forward to either
“gynecological consultation at follow-up” or “visit to a
specialist clinic of choice” while those who did not kept
wondering what to do.
Sources of information that were discussed included
newspapers, television, the Internet, patient groups, and
nurses. The adverse effect most often mentioned with
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woman recalled finding an article about lymphedema in
a newspaper. “I happened to find an article in a medical
newspaper that described a doctor who left the univer-
sity and opened a clinic. With that information, I visited
there.” (#28, 7 years after treatment)
The Internet was mentioned as a source of informa-
tion by patients and their family members. One woman,
whose doctor stated that he was not aware of the symp-
tom after the patient complained about her swollen leg
at follow-up, said that her daughter discovered online a
medical institution for treatment. “My daughter searched
the Internet and found a local medical university’s vascu-
lar surgery department that appeared to do some-
thing. . .The doctor there said the symptom would last a
lifetime and told me to use a special German-made
stocking. It was from that doctor that I first understood
that I was suffering from lymphedema.” (#13, 9 years
after treatment)
Newspaper articles or Internet searches were the
source of information on patient groups. One woman
mentioned that she immediately contacted a patient
group that held regular meetings at a local community
center when she first experienced signs of lymphedema.
“I met a patient with a swollen leg during my hospital
stay. She did not receive any treatment. I thought the
hospital would not provide treatment if I developed a
symptom, so I searched for a patient group by myself
and made a contact.” (#07, 6 years after treatment)
Nurses were unofficial sources of information. Some
women spoke to the nurses with whom they had become
acquainted during their hospital stay, while others talked
with nurse or ex-nurse friends. “My doctor first told me
it wasn’t serious and just prescribed Kampo [Chinese
herbal medicine]. The symptom was not bad when I saw
him because it was always in the morning, but it got
worse at night. . . .it was around that time my ex-nurse
friend warned me. She told me I should take care, other-
wise it could become serious.” (#12, 1 year after
treatment)
After obtaining information on symptoms, women ei-
ther visited clinics or talked to their gynecologists about
the information at the follow-up. For example, one
woman realized her leg had swollen when she attended a
lecture on lymphedema hosted by a patient group. She
consulted a gynecologist at the next follow-up visit, but
he provided no treatment. After consultation, she met a
nurse she had known since treatment and explained the
situation. “I showed my leg to the doctor, but he said
‘Well, anyone’s leg can get swollen this much.’. . .As I
was wondering what to do, I saw a head nurse with
whom I talked a lot during my hospital stay. . .She said
‘It’s better to visit a specialist,’ so I did. My lymphedema
turned out to be in an early stage. . .I think my legwould’ve been much worse if I hadn’t attended the lec-
ture hosted by the patient group.” (#06, 6 years after
treatment)
Discussion
This is the first qualitative study to explore the care-
seeking behaviors of Japanese gynecological cancer sur-
vivors suffering from post-treatment adverse effects. Al-
though our data are drawn from 28 participants, this
study aims to extract variations in care seeking experi-
ences and the sample size was considered to be adequate
because the analysis reached data saturation, in which
no new categories and category–category connections
were extracted [21,22].
The result revealed 2 pathways to treatment
(“gynecological consultation at follow- up” and “visit to
specialist clinic of choice”) and 3 factors affecting care-
seeking behaviors (“knowledge and interpretation,”
“non-treatment,” and “obtaining information through
people and media”).
Survivors used follow-up consultations as opportunities
to receive care for adverse effects. Strikingly, however,
women’s stories revealed that follow-up consultations did
not always result in symptom investigation or treatment.
In those cases, symptoms often continued and even wor-
sened. Delays in treatment of adverse effects were asso-
ciated with the attitudes of gynecologists during follow-up
visits, indicating that provider delays affect treatment of
survivors suffering from adverse effects, as in cancer diag-
nosis [23,24].
This study also revealed that gynecological cancer sur-
vivors seek care at a variety of clinics outside of follow-
up consultations. This is possible in Japan, where
patients have a free choice of service providers under
the universal health insurance system. In this study,
women visited neighborhood clinics of choice when they
suspected symptoms not to be related to cancer treat-
ment, when they did not receive care at follow-up, or if
they did not have high expectations for a good outcome
after gynecological consultation. In these instances, pa-
tient delays occurred while they wondered about symp-
toms and which clinic to visit. The freedom to choose
any clinic, and not the one recommended by gynecolo-
gists at follow-ups, may bring a lack of continuity in care
and a loss of precious information essential for the clin-
ician to guide the patient through treatment.
These observations also strongly indicate that Japanese
gynecological cancer survivors have needs for the man-
agement of adverse effects. Previous quantitative studies
revealed that gynecological cancer survivor with lymphe-
dema have more unmet physical and informational
needs and that those with physical sequelae reported
lower levels of meaning in life, which was associated
with higher levels of depressive symptoms [6,25]. In
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have needs for comprehensive cancer care, which include
communication with doctors and use of local health care
services [3]. Another survey on survivors of various cancer
types, including gynecological cancer, reported high needs
for and low satisfaction with information on long-term
side effects [26]. Taken together, it is suggested that more
emphasis should be placed on doctor-patient coordination
and provision of care for prolonged post-treatment symp-
toms of gynecological cancer survivors.
From participants’ accounts shown in the result, they
sought care both during and outside of follow-up re-
gardless the time from the treatment completion. The
women’s narrative about their symptoms and care-
seeking behaviors highlight that not only the type of
symptoms but how they seek care affects the outcome
and duration of the post-treatment symptoms. It indi-
cates that there are some women who resume normal
daily lives without realizing that they may need help for
their symptoms caused by cancer and its treatment.
Furthermore, the strong dissatisfaction about the lack
of care was expressed by those who finished the treat-
ment relatively recently. There are 2 possible explana-
tions for these observations. One explanation is that the
care for post-treatment adverse effects has not been
much improved. Those for whom many years have
passed since treatment may accept their symptoms or be
used to the lack of care. Another explanation is that
those for whom the treatment is recent feels stronger
care needs for adverse effects.
Information obtained from sources other than medical
institutions, including mass media and patient groups,
played an important role for patients in reaching proper
treatment. The observation that patients did not receive
enough information from medical institutions is in accord
with a previous study reporting that cancer survivors did
not receive information needed to cope with debilitating
symptoms [27]. These findings highlight the need to ex-
plore the scope and role of follow-up programs for the care
of cancer survivors. Other studies have pointed out that
cancer survivors do not receive all the information they
need about sequelae and their treatment during follow-up
care [28,29]. However, a fully developed and standardized
model for providing follow-up care service does not exist
[1]. In the case of gynecological cancer, follow-ups primar-
ily focus on disease recurrence, and patients consider this
aspect of follow-up to be the most important [30,31]. A
recurrence-oriented consultation may delay seeking and
providing care for adverse effects; this may be an important
area of research, to explore the role of follow-up in caring
for adverse effects and in providing patients with informa-
tion on how to obtain appropriate treatment for such
effects. Studies focusing on Survivorship Care Plans or on
different follow-up care models, as undertaken in othercountries, may be a way forward. However, in Japan, open
discussion about policies or guidelines for follow-up care is
rare. At the very least, medical professionals engaged in
follow-up programs should encourage patients to express
their symptoms during consultation, and care providers
should pay much more attention to the detection and
treatment of adverse effects.
Our study also shows that whether and how survivors
initiate care-seeking behavior depends on their knowledge
and interpretation of their symptoms. Survivors’ know-
ledge about adverse effects came from consultations before
surgery and at the time of discharge. Uninformed survivors
often failed to identify and acknowledge the presence of
signs and symptoms. They also failed to relate the symp-
toms they experienced to their cancer treatment. In
contrast, informed survivors sought care at follow-up con-
sultations or clinics specializing in treating their symptoms.
Studies on delays in cancer diagnosis have previously iden-
tified the role of knowledge and interpretation [32-34]. The
results of the present study emphasize the importance of
raising awareness of adverse effects in gynecological cancer
treatment so that survivors interpret signs and symptoms
correctly and take timely and appropriate action.
Andersen’s model of total patient delay describes delays
caused by both patients and health professionals [35]. This
model was proposed for cancer diagnosis and then applied
to various other diseases as a framework to explore help-
seeking behavior [36]. Delays documented in this study are
consistent with what Andersen calls “appraisal,” “illness,”
“behavioral,” and “treatment” delays. In the present study,
appraisal delay occurred when gynecological cancer survi-
vors failed to interpret signs and symptoms as those requir-
ing medical attention. Illness delay occurred when
survivors postponed seeking medical help, and behavioral
delay occurred when survivors wondered where to seek
help. These delays are patient-related; however, this study
suggests that the lack of information provided by health-
care professionals before discharge also contributes to
increased delays. Treatment delay occurred when survivors
consulted a gynecologist at follow-up but received neither
treatment nor referral. Previous studies on help-seeking for
cancer symptoms revealed that healthcare professionals’
“poor advice,” non-investigation of symptoms, and lack of
referrals caused delays in cancer diagnosis [23,24]. The
present study suggests that Andersen’s model could be
used to formulate guidelines to improve the treatment of
adverse effects in Japanese gynecological cancer survivors.
This study has several limitations. First, because the
participants came from a specific patient group, our
findings might not be generalized to the cancer survivor
population as a whole. Second, there may be a volunteer
bias and those who have unsatisfied post-treatment
experiences may be more likely to participate in the
study. Third, there may be a recall bias and their
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ences. Fourth, since participants were recruited from dif-
ferent hospitals, their experience may have reflected the
local protocols of those hospitals.
In addition, we were not able to confirm delays experi-
enced by survivors who visited a clinic of their choice but
did not receive appropriate treatment, although this could
fit into the category of treatment delay. Furthermore, we
were unable to explore the behaviors of patients after re-
ceiving their initial treatment for post-treatment symp-
toms, and therefore such information is lacking.
Nonetheless, this study offers new and useful insights
into care-seeking behaviors and treatment delay after
cancer treatment. Cross-sectional surveys of randomly
selected survivors will determine the characteristics of
those with unresolved survivorship concerns. Further-
more, prospective studies will provide information about
the process of post-treatment care-seeking behaviors.
Conclusion
Awareness of possible adverse effects of both the disease
and the treatment is important for gynecological cancer
survivors so that they may obtain appropriate care if the
need arises. Patients should receive detailed information
about the signs and symptoms of these effects at discharge
in such a way that they can adequately interpret any devel-
oping symptoms. Medical professionals engaged in follow-
up programs should routinely encourage patients to express
their symptoms and concerns during follow-up consultation
in order to make a differential diagnosis of reported
symptoms for referrals and/or additional treatment.Competing interest
The authors declare that they have no competing interest.
Authors’ contribution
SO conducted the focus group discussions and the initial data analysis and
drafted the manuscript. KK, TT, and HK participated in data analysis. MM
checked data validity. All authors read and approved the final manuscript.
Acknowledgments
The authors wish to express their gratitude to all participants and the
gynecological cancer support group for their valuable contributions.
Author details
1Department of Healthcare Systems Research, Graduate School of Medicine,
Hokkaido University, Sapporo, Japan. 2Department of Psychology and
Communication, School of Humanities, Hokusei Gakuen University, 2-3-1
Oyachi-nishi, Atsubetsu-ku, Sapporo 004-8631, Japan. 3Faculty of Health
Sciences, Hokkaido University, Sapporo, Japan.
Received: 3 November 2011 Accepted: 19 December 2012
Published: 8 January 2013
References
1. Aziz NM: Cancer survivorship research: state of knowledge, challenges
and opportunities. Acta Oncol 2007, 46:417–432.
2. Park SY, Bae DS, Nam JH, Park CT, Cho CH, Lee JM, Lee MK, Kim SH, Park SM, Yun
YH: Quality of life and sexual problems in disease-free survivors of cervical
cancer compared with the general population. Cancer 2007, 110:2716–2725.3. Hodgkinson K, Butow P, Fuchs A, Hunt GE, Stenlake A, Hobbs KM, Brand A,
Wain G: Long-term survival from gynecologic cancer: psychosocial
outcomes, supportive care needs and positive outcomes. Gynecol Oncol
2007, 104:381–389.
4. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P,
Bevers TB, Levenback CF, Gershenson DM, Bodurka DC: Quality of life and
sexual functioning in cervical cancer survivors. J Clin Oncol 2005, 23:7428–7436.
5. Greimel ER, Winter R, Kapp KS, Haas J: Quality of life and sexual
functioning after cervical cancer treatment: a long-term follow-up study.
Psychooncology 2009, 18:476–482.
6. Simonelli LE, Fowler J, Maxwell GL, Andersen BL: Physical sequelae and
depressive symptoms in gynecologic cancer survivors: meaning in life as
a mediator. Ann Behav Med 2008, 35:275–284.
7. Wenzel LB, Donnelly JP, Fowler JM, Habbal R, Taylor TH, Aziz N, Cella D:
Resilience, reflection, and residual stress in ovarian cancer survivorship: a
gynecologic oncology group study. Psychooncology 2002, 11:142–153.
8. Beesley V, Janda M, Eakin E, Obermair A, Battistutta D: Lymphedema after
gynecological cancer treatment: prevalence, correlates, and supportive
care needs. Cancer 2007, 109:2607–2614.
9. Ganz PA: Monitoring the physical health of cancer survivors: a
survivorship-focused medical history. J Clin Oncol 2006, 24:5105–5111.
10. Colombo N, Peiretti M, Parma G, Lapresa M, Mancari R, Carinelli S, Sessa C,
Castiglione M, Esmo Guidelines Working Grp: Newly diagnosed and
relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines
for diagnosis, treatment and follow-up. Ann Oncol 2010,
21(suppl 5):v23–v30.
11. Haie-Meder C, Morice P, Castiglione M, Esmo Guidelines Working Grp:
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up. Ann Oncol 2010, 21(suppl 5):v37–v40.
12. Plataniotis G, Castiglione M, Esmo Guidelines Working Grp: Endometrial
cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and
follow-up. Ann Oncol 2010, 21(suppl 5):v41–v45.
13. Shibuya K, Hashimoto H, Ikegami N, Nishi A, Tanimoto T, Miyata H, Takemi
K, Reich MR: Future of Japan's system of good health at low cost with
equity: beyond universal coverage. Lancet 2011, 378:1265–1273.
14. Mabuchi S, Isohashi F, Maruoka S, Hisamatsu T, Takiuchi T, Yoshioka Y,
Kimura T: Post-treatment follow-up procedures in cervical cancer
patients previously treated with radiotherapy. Arch Gynecol Obstet 2012,
286:179–185.
15. Pope C, Mays N: Qualitative Research in Health Care. 3rd edition. Malden:
Blackwell Publishing; 2006.
16. O'Mahony M, Hegarty J: Help seeking for cancer symptoms: a review of
the literature. Oncol Nurs Forum 2009, 36:E178–E184.
17. Smith LK, Pope C, Botha JL: Patients' help-seeking experiences and delay
in cancer presentation: a qualitative synthesis. Lancet 2005, 366:825–831.
18. Kitzinger J: Qualitative research. Introducing focus groups. BMJ 1995,
311(7000):299–302.
19. King N, Horrocks C: Interviews in Qualitative Research. London: Sage
Publications; 2010.
20. Miles MB, Huberman AM: Qualitative Data Analysis: An Expanded Sourcebook.
2nd edition. London: Sage Publications; 1994.
21. Pope C, Ziebland S, Mays N: Qualitative research in health care. Analysing
qualitative data. BMJ 2000, 320:114–116.
22. Glaser B, Strauss A: The Discovery of Grounded Theory: Strategies for
Qualitative Research. Chicago: Aldine Transaction; 1967.
23. Facione NC: Delay versus help seeking for breast cancer symptoms: a
critical review of the literature on patient and provider delay. Soc Sci Med
1993, 36:1521–1534.
24. Evans J, Ziebland S, McPherson A: Minimizing delays in ovarian cancer
diagnosis: an expansion of Andersen's model of 'total patient delay'.
Fam Pract 2007, 24:48–55.
25. Beesley V, Eakin E, Steginga S, Aitken J, Dunn J, Battistutta D: Unmet needs
of gynaecological cancer survivors: implications for developing
community support services. Psychooncology 2008, 17:392–400.
26. McInnes DK, Cleary PD, Stein KD, Ding L, Mehta CC, Ayanian JZ:
Perceptions of cancer-related information among cancer survivors: a
report from the American Cancer Society's Studies of Cancer Survivors.
Cancer 2008, 113:1471–1479.
27. Beaver K, Latif S, Williamson S, Procter D, Sheridan J, Heath J, Susnerwala S,
Luker K: An exploratory study of the follow-up care needs of patients
treated for colorectal cancer. J Clin Nurs 2010, 19:3291–3300.
Oshima et al. BMC Women's Health 2013, 13:1 Page 9 of 9
http://www.biomedcentral.com/1472-6874/13/128. Pun Wong DK, Chow SF: A qualitative study of patient satisfaction with
follow-up cancer care: the case of Hong Kong. Patient Educ Couns 2002,
47:13–21.
29. Gray RE, Fitch M, Greenberg M, Hampson A, Doherty M, Labrecque M: The
information needs of well, longer-term survivors of breast cancer. Patient
Educ Couns 1998, 33:245–255.
30. Kew FM, Galaal K, Manderville H: Patients' views of follow-up after
treatment for gynaecological cancer. J Obstet Gynaecol 2009, 29:135–142.
31. Lydon A, Beaver K, Newbery C, Wray J: Routine follow-up after treatment
for ovarian cancer in the United Kingdom (UK): Patient and health
professional views. Eur J Oncol Nursing 2009, 13:336–343.
32. De Nooijer J, Lechner L, De Vries H: Help-seeking behaviour for cancer
symptoms: perceptions of patients and general practitioners.
Psychooncology 2001, 10:469–478.
33. Scott SE, Grunfeld EA, Main J, McGurk M: Patient delay in oral cancer: a
qualitative study of patients' experiences. Psychooncology 2006,
15:474–485.
34. Macleod U, Mitchell ED, Burgess C, Macdonald S, Ramirez AJ: Risk factors
for delayed presentation and referral of symptomatic cancer: evidence
for common cancers. Br J Cancer 2009, 101(Suppl 2):S92–S101.
35. Andersen BL, Cacioppo JT: Delay in seeking a cancer diagnosis: delay
stages and psychophysiological comparison processes. Br Soc Psychol
1995, 34:33–52.
36. Scott S, Walter F: Studying help-seeking for symptoms: the challenges of
methods and models. Soc Pers Psychol Compass 2010, 4:531–547.
doi:10.1186/1472-6874-13-1
Cite this article as: Oshima et al.: Care-seeking behavior of Japanese
gynecological cancer survivors suffering from adverse effects. BMC
Women's Health 2013 13:1.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
